Powered by Google

2018-21: A Two-Year, Three-Arm, Randomized, Double-Masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of Brolucizumab versus Aflibercept in Adult Patients with Visual Impairment due to Diabetic Macular Edema (KESTREL)

Medical retina
Drug research
Investigator Initiated Research
Inclusion open since 1-3-2019

This study is designed to evaluate the efficacy and safety of

brolucizumab in treatment of patients with visual impairment due to

diabetic macular edema (DME).

By visiting eyehospital.nl you are accepting the use of cookies. Read more about cookies.

Hide this message